Female infertility refers to infertility in female humans. It affects an estimated 48 million women with the highest prevalence of infertility affecting people in South Asia, Sub-Saharan Africa, North Africa/Middle East, and Central/Eastern Europe and Central Asia. Infertility is caused by many sources, including nutrition, diseases, and other malformations of the uterus. Infertility affects women from around the world.
The Female infertility Treatment Program includes the following:
Laboratory Tests which includes:
- Erythrocyte sedimentation rate
- Differential white blood cell count
- Blood type and RH factor Complete coagulation test
- CBC test
- Quantitative serology test
- Venereal Disease Research Laboratory (VDRL) test
- HIV test
- Cyturia test
- Glycemia test
- Creatinine test
- FSH (Follicle Stimulating Hormone) and LH (Lutenizing Hormone)
- Estrogen test
- Progesterone and prolactin test
Other tests:
- Vaginal discharge and vaginal cytology;
- Sperm penetration test; and Cervical test
Imaging studies:
- Hysterosalpingography;
- Skull and Sella radiography; and
- Transvaginal ultrasound
Instrumentation and diagnostic examination:
- Contrasted Laparoscopy.
PLEASE NOTE THE FOLLOWING IMPORTANT INFORMATION:
- The above program does not include medications for certain conditions such as depression, blood coagulation, etc.
- Medicaments, fluids, blood and derivatives to be used, as well as additional procedure(s) performed not included in the exact treatment would be invoiced separately on upon the conclusion of said treatment / procedure(s)